Clinical Trial Update: R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing R-CHOP versus R-mini-CEOP in elderly patients with diffuse large B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Elderly Patients (>65 Years), Diffuse Large B Cell Lymphoma (DLBCL) | Phase 3 | Status: COMPLETED